Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

about

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

Item

http://www.wikidata.org/entity/Q57822410

description

scientific article published on 07 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

@en

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

@nl

type

Item

label

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

@en

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

@nl

prefLabel

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

@en

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

@nl

P1476

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

@en

P2093

Charlotte E Teunissen

http://www.w3.org/2001/XMLSchema#string

John C van Swieten

http://www.w3.org/2001/XMLSchema#string

Kelly Watts

http://www.w3.org/2001/XMLSchema#string

Lynn Boonkamp

http://www.w3.org/2001/XMLSchema#string

Naura Elias

http://www.w3.org/2001/XMLSchema#string

Tommaso Beccari

http://www.w3.org/2001/XMLSchema#string

Yolande A Pijnenburg

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.

Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid

The Alzheimer's disease mitochondrial cascade hypothesis

P304

1163-1175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.629

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349851

http://www.w3.org/2001/XMLSchema#string

P932

6186934

http://www.w3.org/2001/XMLSchema#string